Full Text
HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiation Outcomes in Canada? Comparison of Rare Disease and Oncology Drugs

Abstract

Authors

Y Privolnev A Liovas N Jakac-Sinclair

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×